Abstract

BackgroundN6-methyladenosine (m6A) is an important epigenetic modification which plays various roles in mRNA metabolism and embryogenesis directly related to human diseases. To identify m6A in a large scale, machine learning methods have been developed to make predictions on m6A sites. However, there are two main drawbacks of these methods. The first is the inadequate learning of the imbalanced m6A samples which are much less than the non-m6A samples, by their balanced learning approaches. Second, the features used by these methods are not outstanding to represent m6A sequence characteristics.ResultsWe propose to use cost-sensitive learning ideas to resolve the imbalance data issues in the human mRNA m6A prediction problem. This cost-sensitive approach applies to the entire imbalanced dataset, without random equal-size selection of negative samples, for an adequate learning. Along with site location and entropy features, top-ranked positions with the highest single nucleotide polymorphism specificity in the window sequences are taken as new features in our imbalance learning. On an independent dataset, our overall prediction performance is much superior to the existing predictors. Our method shows stronger robustness against the imbalance changes in the tests on 9 datasets whose imbalance ratios range from 1:1 to 9:1. Our method also outperforms the existing predictors on 1226 individual transcripts. It is found that the new types of features are indeed of high significance in the m6A prediction. The case studies on gene c-Jun and CBFB demonstrate the detailed prediction capacity to improve the prediction performance.ConclusionThe proposed cost-sensitive model and the new features are useful in human mRNA m6A prediction. Our method achieves better correctness and robustness than the existing predictors in independent test and case studies. The results suggest that imbalance learning is promising to improve the performance of m6A prediction.

Highlights

  • N6-methyladenosine (m6A) is an important epigenetic modification which plays various roles in mRNA metabolism and embryogenesis directly related to human diseases

  • Datasets Currently validated human mRNA m6A sites were all obtained by Ke and Linda from single nucleotide resolution maps [33, 34]

  • To demonstrate the robustness of our method to deal with the unknown percentages of positive samples in real transcripts, we compared our method with three existing human m6A predictors on datasets of different positiveand-negative sample ratios

Read more

Summary

Introduction

N6-methyladenosine (m6A) is an important epigenetic modification which plays various roles in mRNA metabolism and embryogenesis directly related to human diseases. Among more than 140 kinds of post-transcription modifications (PTMs) [1, 2], N6-methylation (m6A)—the methylation at 6th nitrogen of adenosine, is one of the most abundant modifications [3, 4] This methylation has been widely found in species such as Arabidopsis thaliana, Saccharomyces cerevisiae, bacteria, virus, human, and mouse [5,6,7,8]. These methylation events have occurred in the mRNAs at the 3’ untranslated. Strong relationships have been observed between m6A and HIV-1 [20, 21], Zika

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call